Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

This article affects  the problems of using NOAC in the most defenseless groups  of patients with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
Format: Artigo
Idioma:Inglês
Publicat: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Col·lecció:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Matèries:
atrial fibrillation
difficult patients
elderly
rivaroxaban
warfarin
Accés en línia:https://www.rpcardio.com/jour/article/view/1769
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars